Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach

被引:15
|
作者
Tilangi, Praveen [1 ]
Desai, Devashish [1 ]
Khan, Adil [1 ]
Soneja, Manish [1 ]
机构
[1] All India Inst Med Sci, Dept Med, New Delhi 110029, India
来源
LANCET INFECTIOUS DISEASES | 2020年 / 20卷 / 10期
关键词
D O I
10.1016/S1473-3099(20)30430-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:1119 / 1120
页数:2
相关论文
共 50 条
  • [21] Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis
    Singer, Mendel E.
    Kaelber, David C.
    Antonelli, Maria J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (09)
  • [22] Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19
    Hernandez, Adrian V.
    Roman, Yuani M.
    Pasupuleti, Vinay
    Barboza, Joshuan J.
    White, C. Michael
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 173 (04) : W78 - W79
  • [23] Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
    Pareek, Anil
    Bhandari, Sudhir
    Mehta, Ravi Tejraj
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 152 (01) : 130 - 132
  • [24] Covid-19: Hydroxychloroquine was ineffective as postexposure prophylaxis, study finds
    Mahase, Elisabeth
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369 : m2242
  • [25] Generalized exanthema due to hydroxychloroquine during COVID-19 prophylaxis
    Kutlu, Omer
    Ozdemir Cetinkaya, Pinar
    Aktas, Habibullah
    Metin, Ahmet
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (02)
  • [26] Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
    Shankar, Pathiyil
    Palaian, Subish
    Gulam, Shabaz
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2021, 13 (01): : 4 - 10
  • [27] Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19
    Kulkarni, Chanda
    Sadiq, Adil
    Gigi, Arya
    Devassia, Ambili
    George, Georgeena
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (05) : 420 - 421
  • [28] Estimating the Impact of Covid-19 Outbreak on High-Risk Age Group Population in India
    Harjit Pal Singh
    Vikas Khullar
    Monica Sharma
    [J]. Augmented Human Research, 2020, 5 (1)
  • [29] Risk of using hydroxychloroquine as a treatment of COVID-19
    Alanagreh, Lo'ai
    Alzoughool, Foad
    Atoum, Manar
    [J]. INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2020, 31 (03): : 111 - 116
  • [30] Hydroxychloroquine and COVID-19
    Sinha, Neeraj
    Balayla, Galit
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2020, 96 (1139) : 550 - 555